We work with

CAR-T, CAR-NK Cells

For autologous and allogeneic therapies

Stem Cells

For relevant therapies

Key Attributes We Improve

Card 1
Card 2
Card 3
Card 3
Card 3
Card 1
Card 2
Card 3
Card 3
Card 3

How It Works

1 | Process Characterisation

We begin by thoroughly characterising your current process, gathering data on metabolite consumption, cell performance, and critical process parameters like dO2, NH4 etc.

This data allows us to map the existing metabolic state of your cells.


2 | Optimise Media Composition

Harnessing the power of machine learning and AI, combined with our proprietary computational framework and extensive internal datasets, we design and manufacture the optimal media composition.

This advanced approach precisely tunes your cells' metabolic state to drive targeted phenotypic changes, such as enhanced growth and improved endurance markers, ensuring peak cellular performance.

3 | Manufacture, Quality Control & Validation

Our team manufactures small batches, then rigorously tests the new media to meet stringent QC requirements in-house.

Once it passes internal validation, we collaborate with you to verify that it meets your product’s Critical Quality Attributes (CQAs).


We offer tailored solutions for manufacturers at every stage of development, including milestone-based media licensing to minimise risk. Our approach ensures you receive the right support and seamless translation from research to clinical and commercial success.

Media Delivery

Sign up to our early access programme